LOADING
Lung cancer is one of the most impactful diagnoses any veteran can face, and it has a clear compensation pathway through multiple presumptive frameworks. The PACT Act expanded presumptive service connection for lung cancer for veterans exposed to burn pits. Agent Orange presumption has long covered lung cancer for Vietnam-era veterans. Atomic veterans have radiation-related presumption. Understanding how the rating works during active treatment and after, and which presumptive frameworks apply, helps affected veterans and their families navigate the claim process.
Lung cancer is rated under Diagnostic Code 6819 within 38 CFR 4.97. The initial rating for active malignant neoplasms of the respiratory system is 100 percent. This rating continues for at least six months following the cessation of surgical, X-ray, antineoplastic chemotherapy, or other therapeutic procedure. After that six-month period, a mandatory re-examination evaluates residuals.
Residuals are rated based on any remaining lung function impairment. Residual lung cancer effects are often rated under DC 6840 through 6845 for restrictive lung disease, using pulmonary function test values. The rating criteria use FEV1 percent of predicted, FVC percent of predicted, FEV1/FVC ratio, and diffusion capacity (DLCO).
A 10 percent rating applies when FEV1 is 71 to 80 percent predicted, or FVC is 75 to 80 percent predicted, or DLCO is 66 to 80 percent predicted, or maximum exercise capacity is 15 to 20 METs. A 30 percent rating applies for FEV1 56 to 70 percent predicted, FVC 65 to 74 percent predicted, DLCO 56 to 65 percent predicted, or maximum exercise capacity 10 to 15 METs. A 60 percent rating applies for FEV1 40 to 55 percent predicted, FVC 50 to 64 percent predicted, DLCO 40 to 55 percent predicted, or maximum exercise capacity 3 to 10 METs. A 100 percent rating applies for FEV1 less than 40 percent predicted, FVC less than 50 percent predicted, DLCO less than 40 percent predicted, maximum exercise capacity less than 3 METs, cor pulmonale (right heart failure), right ventricular hypertrophy, pulmonary hypertension, episodes of respiratory failure, or requiring outpatient oxygen therapy.
Surgical residuals from lung cancer treatment often produce reduced lung function due to lobectomy or pneumonectomy (removal of part or all of a lung). Partial lobectomy typically produces less functional impairment than pneumonectomy. The rating reflects actual pulmonary function, not the type of surgery performed.
Chemotherapy and radiation residuals can include pulmonary fibrosis, radiation pneumonitis, and other long-term complications. These residuals are rated based on their functional impact on pulmonary and overall health.
The PACT Act made lung cancer presumptive for veterans with qualifying burn pit exposure. Veterans who served in the Southwest Asia theater, Iraq, Afghanistan, Djibouti, Syria, Jordan, Lebanon, Yemen, Egypt, or other covered locations during specified periods, and who develop lung cancer, qualify for presumptive service connection under 38 CFR 3.320.
Agent Orange presumption covers lung cancer for Vietnam-era veterans. Under 38 CFR 3.309(e), respiratory cancers including lung cancer are presumptive for veterans who served in Vietnam, Thailand, Korean DMZ, and other covered locations during specified periods. The PACT Act expanded covered locations to include additional Thailand bases and other installations.
Atomic veterans have presumption for lung cancer under 38 CFR 3.309(d). Veterans who participated in atmospheric nuclear testing, Hiroshima/Nagasaki occupation, or other qualifying radiation exposure events qualify for presumptive lung cancer service connection.
Evidence for a lung cancer claim includes pathology reports confirming the diagnosis, treatment records including surgery, chemotherapy, and radiation, imaging studies showing the cancer and treatment response, pulmonary function tests for residual assessment, oncology consultation notes, DD-214 and deployment records establishing qualifying service for presumption, and a list of current medications.
The post-treatment re-examination is the critical point where long-term compensation is determined. Prepare for this examination by documenting all residuals including shortness of breath, exercise limitations, oxygen use if prescribed, chronic cough, weight loss, fatigue, and any ongoing cancer surveillance. Bring recent pulmonary function test reports, imaging results, and oncology follow-up notes.
Secondary conditions from lung cancer and its treatment are common. Depression and anxiety affect many cancer survivors and can be separately rated. Chronic pain from surgery can be rated. Radiation therapy can cause cardiac complications, esophageal damage, and other residuals that may warrant separate ratings.
Surviving family members should pursue DIC if a veteran dies of lung cancer that was service-connected or presumptively service-connected. Under 38 USC 1310, DIC provides substantial monthly benefits to surviving spouses and dependents. For veterans who did not file claims during their lifetime, survivors can pursue posthumous service connection and DIC.
Veterans previously denied lung cancer claims based on pre-PACT Act or pre-Blue Water Navy Act criteria should file supplemental claims under the new presumptive frameworks. The change in presumptive eligibility qualifies as new and relevant evidence under 38 CFR 3.2501.
The ClaimRecon Rating Calculator models how the 100 percent active cancer rating combines with other service-connected conditions and how residual ratings may affect long-term compensation. The C&P Exam Simulator prepares you for the post-treatment re-examination and respiratory conditions DBQ. The Secondary Condition Finder maps lung cancer to its treatment residuals and secondary conditions. The Personal Statement Builder helps you document treatment history, current residuals, and functional impact.
Disclaimer: This article is for educational and informational purposes only. It does not constitute legal, medical, or VA claims advice. Presumptive provisions and rating criteria are subject to change. Always verify current criteria at VA.gov or consult with an accredited VSO, attorney, or claims agent before making decisions about your benefits.
Written by ClaimRecon Editorial